https://www.med-guidelines.org.uk/index.php?action=history&feed=atom&title=Anticoagulants 2026-05-04T15:50:04Z Revision history for this page on the wiki MediaWiki 1.34.1 https://www.med-guidelines.org.uk/index.php?title=Anticoagulants&diff=2134&oldid=prev 2025-03-05T10:10:35Z

<p><span dir="auto"><span class="autocomment">Acceptability at CT / Work-Up</span></span></p> <table class="diff diff-contentalign-left" data-mw="interface"> <col class="diff-marker" /> <col class="diff-content" /> <col class="diff-marker" /> <col class="diff-content" /> <tr class="diff-title" lang="en"> <td colspan="2" style="background-color: #fff; color: #222; text-align: center;">← Older revision</td> <td colspan="2" style="background-color: #fff; color: #222; text-align: center;">Revision as of 10:10, 5 March 2025</td> </tr><tr><td colspan="2" class="diff-lineno" id="mw-diff-left-l2" >Line 2:</td> <td colspan="2" class="diff-lineno">Line 2:</td></tr> <tr><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>QUALIFIED </div></td><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>QUALIFIED </div></td></tr> <tr><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"></td><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"></td></tr> <tr><td class='diff-marker'>−</td><td style="color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div>==Acceptability at <del class="diffchange diffchange-inline">CT </del>/ Work-Up==</div></td><td class='diff-marker'>+</td><td style="color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div>==Acceptability at <ins class="diffchange diffchange-inline">VT </ins>/ Work-Up==</div></td></tr> <tr><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>QUALIFIED</div></td><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>QUALIFIED</div></td></tr> <tr><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"></td><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"></td></tr> <!-- diff cache key localdb-mw_:diff::1.12:old-608:rev-2134 --> </table>

Frances.Sarkari@anthonynolan.org https://www.med-guidelines.org.uk/index.php?title=Anticoagulants&diff=608&oldid=prev 2012-06-19T11:13:03Z

<p>Protected &quot;<a href="/Anticoagulants" title="Anticoagulants">Anticoagulants</a>&quot; (‎[edit=sysop] (indefinite) ‎[move=sysop] (indefinite))</p> <table class="diff diff-contentalign-left" data-mw="interface"> <col class="diff-marker" /> <col class="diff-content" /> <col class="diff-marker" /> <col class="diff-content" /> <tr class="diff-title" lang="en"> <td colspan="2" style="background-color: #fff; color: #222; text-align: center;">← Older revision</td> <td colspan="2" style="background-color: #fff; color: #222; text-align: center;">Revision as of 11:13, 19 June 2012</td> </tr> <!-- diff cache key localdb-mw_:diff::1.12:old-72:rev-608 --> </table>

Dr Robert Lown https://www.med-guidelines.org.uk/index.php?title=Anticoagulants&diff=72&oldid=prev 2012-06-12T11:12:27Z

<p></p> <table class="diff diff-contentalign-left" data-mw="interface"> <col class="diff-marker" /> <col class="diff-content" /> <col class="diff-marker" /> <col class="diff-content" /> <tr class="diff-title" lang="en"> <td colspan="2" style="background-color: #fff; color: #222; text-align: center;">← Older revision</td> <td colspan="2" style="background-color: #fff; color: #222; text-align: center;">Revision as of 11:12, 12 June 2012</td> </tr><tr><td colspan="2" class="diff-lineno" id="mw-diff-left-l24" >Line 24:</td> <td colspan="2" class="diff-lineno">Line 24:</td></tr> <tr><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>==Pseudonyms or Related Conditions==</div></td><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>==Pseudonyms or Related Conditions==</div></td></tr> <tr><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>Current anticoagulant drugs commonly used in the UK include:</div></td><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>Current anticoagulant drugs commonly used in the UK include:</div></td></tr> <tr><td class='diff-marker'>−</td><td style="color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div>Warfarin, Phenindione</div></td><td class='diff-marker'>+</td><td style="color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div>Warfarin, Phenindione<ins class="diffchange diffchange-inline">,</ins></div></td></tr> <tr><td class='diff-marker'>−</td><td style="color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div>Heparin, Clexane, Tinzaparin, Fragmin</div></td><td class='diff-marker'>+</td><td style="color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div>Heparin, Clexane, Tinzaparin, Fragmin<ins class="diffchange diffchange-inline">,</ins></div></td></tr> <tr><td class='diff-marker'>−</td><td style="color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div>Danaparoid, Lepirudin, Bivalirudin</div></td><td class='diff-marker'>+</td><td style="color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div>Danaparoid, Lepirudin, Bivalirudin<ins class="diffchange diffchange-inline">,</ins></div></td></tr> <tr><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>Dabigatran, Rivaroxaban</div></td><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>Dabigatran, Rivaroxaban</div></td></tr> <tr><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div> </div></td><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div> </div></td></tr> <!-- diff cache key localdb-mw_:diff::1.12:old-71:rev-72 --> </table>

Dr Robert Lown https://www.med-guidelines.org.uk/index.php?title=Anticoagulants&diff=71&oldid=prev 2012-06-12T11:12:05Z

<p>Page created</p> <p><b>New page</b></p><div>==Acceptability at Recruitment==<br /> QUALIFIED <br /> <br /> ==Acceptability at CT / Work-Up==<br /> QUALIFIED<br /> <br /> ==Individual at Risk==<br /> Donor<br /> <br /> ==Explanation of Condition==<br /> Drugs prescribed most commonly because of a blood clot, such as deep vein thrombosis or pulmonary embolism. They may aslo be given to people with atrial fibrillation who have an increased risk of stroke, or to people who have artificial heart valves.<br /> <br /> ==Guidance==<br /> Unacceptable if currently on anticoagulant therapy.<br /> <br /> If previously on anticoagulation, always establish indication for therapy. Discuss with MO.<br /> <br /> Acceptable if completed a course of anticoagulation for a single episode of deep vein thrombosis. Acceptable if used in pregnancy unless donor has antiphospholipid syndrome or recurrent thrombosis. <br /> <br /> Unacceptable if used for coronary artery disease or valvular heart disease.<br /> <br /> Allow at least 7 days between cessation of coumarin (eg. warfarin) therapy and donation.<br /> <br /> ==Pseudonyms or Related Conditions==<br /> Current anticoagulant drugs commonly used in the UK include:<br /> Warfarin, Phenindione<br /> Heparin, Clexane, Tinzaparin, Fragmin<br /> Danaparoid, Lepirudin, Bivalirudin<br /> Dabigatran, Rivaroxaban<br /> <br /> ==Version== <br /> Version 1, Edition 1<br /> <br /> ====Date of Last Update====<br /> 15th June 2012</div>

Dr Robert Lown